Specify Company / Ticker to Get the Summary
Dividend History ANEB
Dividend Analytics ANEB
Max Ratio
–5Y Dividend Growth
–Consecutive Years
–5Y Average Payout Ratio
–Anebulo Pharmaceuticals Inc
ANEBAnebulo Pharmaceuticals, Inc., a clinical-stage biotechnology company, engages in developing treatments for unintentional cannabis poisoning, acute cannabinoid intoxication, and acute cannabis-induced conditions in the United States. Its lead product candidate is the selonabant, a small molecule antagonist of cannabinoid binding receptor type-1, which is in a phase II clinical trial to address the unmet medical need for a specific antidote for cannabis toxicity. The company was incorporated in 2020 and is based in Lakeway, Texas. Address: 1017 Ranch Road 620 South, Lakeway, TX, United States, 78734
Analytics
WallStreet Target Price
3.00 USDP/E Ratio
–Dividend Yield
–Financials ANEB
Results | 2019 | Dynamics |